InvestorsHub Logo
Followers 1
Posts 36
Boards Moderated 0
Alias Born 11/16/2018

Re: None

Monday, 01/07/2019 12:36:05 PM

Monday, January 07, 2019 12:36:05 PM

Post# of 18784
We are now at day 263 of the European drug approval process. Standing committee consultation should have finished their consultation by January 5th according to EMA guidelines. The ball is now in the European Commisions court now and they have deadline of January 21 (day 277) to report their final decision of Macrilen drug approval in Europe. Thus, Macrilen could conceivably be approved in Europe any day now up until the deadline of January 21st! https://www.ema.europa.eu/documents/presentation/marketing-authorisation-evaluation-process-dr-evdokia-korakianiti_en.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News